2011至2021年Medicare人群中经皮肾活检按专科的趋势:对肾脏病培训要求与放射科转诊模式的影响
该研究基于2011至2021年Medicare全国数据库索赔数据,分析医师与高级执业提供者施行经皮肾活检的量和报销趋势。结果显示总量从30753例增至34090例(10.9%),2019年达峰值37882例;放射科份额从67.6%升至81.1%,内科/肾脏病科从24.3%降至14.3%,高级执业提供者仅从0.9%升至1.2%;报销与非设施RVU均下降。
要点
- 放射科施行经皮肾活检的相对份额从67.6%升至81.1%,内科/肾脏病科从24.3%降至14.3%。
- 经皮肾活检总量从2011年30753例增至2021年34090例(10.9%),2019年峰值37882例。
- 非设施报销从578.96美元降至568.76美元(1.7%),工作RVU从2.63降至2.38(9.5%)。
核心结论
- 研究期间放射科施行的经皮肾活检量和总份额增加,内科/肾脏病科施行的肾活检减少;高级执业提供者施行的经皮肾活检很少;经皮肾活检的报销和RVU下降。
研究设计与样本
- 基于Medicare Part B医师/供应商程序主文件(全国Medicare数据库)2011至2021年索赔数据的分析,使用经皮肾活检的现行程序术语代码提取,按提供者专科比较总量,并比较非设施报销、工作RVU、非设施执业费用RVU和医疗过失RVU。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To study trends in volume and reimbursement for percutaneous kidney biopsy (PKB) by physicians and advanced practice providers (APPs) for Medicare enrollees from 2011-2021.
METHODS: Claims from the Medicare Part B Physician/Supplier Procedure Master File (a national Medicare database) for 2011-2021 were extracted using Current Procedural Terminology codes for PKB. Total volumes were compared by provider specialty. Non-facility reimbursement, work Relative Value Unit (RVU) non-facility practice expense RVU, and malpractice RVU were compared.
RESULTS: Between 2011 and 2021, total volume of PKB by physicians and APPs increased from 30,753 to 34,090 (10.9%), with a peak of 37,882 in 2019 prior to the COVID 19 pandemic. Radiology performed the majority of procedures during the study period. Relative share for radiology increased from 67.6% to 81.1% while the relative share for internal medicine/nephrology decreased from 24.3% to 14.3%, accelerating between 2019 and 2020. Volume and relative share for APPs marginally increased (from 0.9% to 1.2%). Non-facility reimbursement decreased from $578.96 in 2010 to $568.76 in 2021 (1.7%), work RVU decreased from 2.63 to 2.38 (9.5%), non-facility practice expense RVU decreased from 14.10 to 13.71 (2.8%), and malpractice RVU decreased from 0.31 to 0.21 (32.3%).
CONCLUSION: Volume and total share of PKB performed by radiology increased over the study period. Conversely, internal medicine/nephrology performed fewer kidney biopsies. Despite the expanding role for APPs in other image-guided procedures, very few PKBs were performed by APPs throughout the study period. Reimbursement and RVU for PKB declined over the study period.
引用
- Lindquester WS, Chandra A, Dhangana R, et al. Percutaneous kidney biopsy trends in the Medicare population by specialty from 2011 to 2021: implications for nephrology training requirements and radiology referral patterns. Abdom Radiol (NY). 2023. PMID: 37668743. doi:10.1007/s00261-023-04030-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。